Mathieu Lane Hinze, MD Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 4400 Lucile Dr Ste 103, Lincoln, NE 68516 Phone: 402-483-2572 Fax: 402-483-2619 |
Gustavo Rozindo Machado, MD Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 4130 Pioneer Woods Dr Ste 1, Lincoln, NE 68506 Phone: 402-489-4700 Fax: 402-489-5220 |
R Samuel Bryant, MD Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 7001 A St Ste 100, Lincoln, NE 68510 Phone: 402-484-7001 Fax: 402-484-7006 |
Todd Francis Orchard, MD Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 4400 Lucile Dr Ste 103, Lincoln, NE 68516 Phone: 402-483-2572 Fax: 402-483-2619 |
Keli Kolegraff, MD, PHD Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2222 S 16th St Ste 430, Lincoln, NE 68502 Phone: 402-483-8383 Fax: 402-483-8388 |
News Archive
W. L. Gore & Associates (Gore) announced the first human implants of the next generation Conformable GORE TAG® Thoracic Endoprosthesis in the United States for the treatment of traumatic transection of the thoracic aorta.
A lack of comfortable products for the safety of the patient requiring peritoneal dialysis-indicated to clean waste products from the blood when the kidneys fail- drove a student of the Higher Technological Institute of Choapas, Veracruz in the east coast of México, to develop an ergonomic support, allowing that the catheter inserted through the abdominal wall to remain in place and be protected from the invasion of microorganisms.
Researchers at UT Southwestern Medical Center hope they have begun paving a new pathway in the fight against drug dependence. Their hypothesis - that increasing the normally occurring process of making nerve cells might prevent addiction - is based on a rodent study demonstrating that blocking new growth of specific brain nerve cells increases vulnerability for cocaine addiction and relapse.
A multi-center team of researchers led by Children's Hospital of Philadelphia has discovered a genetic signature that could help distinguish an adult-onset form of diabetes sharing many type 1 diabetes characteristics from pediatric-onset T1D, opening the door to potentially more straightforward diagnostic tests for the adult condition and improving responses by ensuring patients receive the most appropriate treatment.
The ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) today announced results from an extended follow-up analysis of patients in its randomized Phase 3 clinical trial, E1912.
› Verified 5 days ago